FDA Inspection 1055676 — Fresenius Kabi
The FDA completed an inspection of Fresenius Kabi on Apr 27, 2018 in Oberursel (Taunus). The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 27, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oberursel (Taunus) (Germany)
Additional Details
Sponsor, Contract Research Organization